Trial Details
UNKNOWNBasic Information
| Clinical ID | c4109 |
|---|---|
| Identifier | NCT01039597 |
| Trial Title | Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Mild to Moderate Ulcerative Colitis |
| Interventions | DRUG: ORE1001|DRUG: Placebo |
Participant Information
| Sponsor | Ore Pharmaceuticals, Inc. |
|---|---|
| City | Ontario |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2009-12 |
|---|---|
| Primary Completion Date | 2011-06 |
| Completion Date | 2011-06 |